Why the study?
Do different classes of antihypertensive agents (nifedipine, timolol, indapamide) differentially affect left ventricular mass and hemodynamics in patients with hypertension?
Do different classes of antihypertensive agents (nifedipine, timolol, indapamide) differentially affect left ventricular mass and hemodynamics in patients with hypertension?
Reduction of left ventricular mass in hypertension is achievable with multiple classes of antihypertensive agents and does not appear to be solely dependent on sympathetic nervous system modulation.
Answers are grounded in this paper and cite their sources.
Supports LV mass reduction across antihypertensive classes; leaves open whether class-specific hemodynamic effects alter outcomes.
We examined the effect of three antihypertensive agents with differing modes of action on blood pressure, heart rate, plasma catecholamines, plasma renin activity, and echocardiographic left ventricular mass. Twenty-six patients were studied; nine were treated with nifedipine, a calcium antagonist, nine were treated with timolol, a nonselective beta-blocker, and eight were treated with indapamide, a diuretic with some probable calcium antagonist properties. All drugs reduced blood pressure satisfactorily; the reduction of systolic blood pressure was not significantly different among the three drugs, but timolol reduced diastolic blood pressure by a greater amount than did either indapamide or nifedipine. Left ventricular (LV) mass was reduced equally by all three drugs. However, there were markedly different effects on the other parameters measured. Heart rate was reduced to a greater extent by timolol than by the other two drugs. Plasma renin activity was reduced by timolol, unchanged by nifedipine, and increased by indapamide. There were no significant changes in either adrenaline or noradrenaline with any of the three drugs. We conclude that these data do not support the hypothesis that the sympathetic nervous system is primarily responsible for left ventricular hypertrophy, and suggest that reduction of left ventricular mass with antihypertensive agents is not the property of any one class of drug.
No takes yet. Share an insight, caveat, or question.
Mace et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: